US2005240015A1PendingUtilityA1

Solution phase synthesis of oligonucleotides

Assignee: AVECIA LTDPriority: Aug 13, 1997Filed: Jun 28, 2005Published: Oct 27, 2005
Est. expiryAug 13, 2017(expired)· nominal 20-yr term from priority
C07F 9/18C07D 265/33Y02P20/55C07H 19/10C07H 19/20C07F 9/165C07H 21/04C07H 21/00C07D 207/48C07H 11/04C07H 1/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for the synthesis in solution phase of a phosphorothioate triester is provided. The process comprises the solution phase coupling of an H-phosphonate with an alcohol in the presence of a coupling agent to form an H-phosphonate diester. The H-phosphonate diester is oxidised in situ with a sulfur transfer agent to produce the phosphorothioate triester. Preferably, the H-phosphonate and alcohol are protected nucleosides or oligonucleotides. Oligonucleotide H-phosphonates which can be used in the formation of phosphorothioate triesters are also provided.

Claims

exact text as granted — not AI-modified
1 - 13 . (canceled)  
   
   
       14 . A process for introducing a group of formula —S-A into an H-phosphonate diester moiety, comprising: reacting a substrate comprising an H-phosphonate diester moiety with a sulfur transfer agent selected from the group consisting of 
 a) compounds of formula:                          wherein A represents an aryl, methyl, substituted alkyl or alkenyl group;    b) compounds of formula:                          wherein A represents an aryl, methyl, substituted alkyl or alkenyl group; and    c) compounds of formula:                          wherein A represents a methyl or alkenyl group.    
   
   
       15 . A process according to  claim 14 , wherein the sulfur transfer agent is selected from the group consisting of  
     
       
         
         
             
             
         
       
     
   
   
       16 . A process according to  claim 14  or  claim 15 , wherein the H-phosphonate diester is an oligonucleotide H-phosphonate diester.  
   
   
       17 . A process according to  claim 16 , wherein the oligonucleotide H-phosphonate diester is a protected oligonucleotide H-phosphonate diester.  
   
   
       18 . A process according to  claim 17 , further comprising one or more subsequent deprotection steps, thereby producing a deprotected oligonucleotide.  
   
   
       19 . A process for the preparation of an oligonucleotide, an oligonucleotide phosphorothioate or a mixed oligonucleotide/oligonucleotide phosphorothioate, said process comprising: introducing a group of formula —S-A into an H-phosphonate diester moiety by the process according to  claim 14 .  
   
   
       20 . A process according to  claim 19 , wherein the sulphur transfer agent is selected from the group consisting of  
     
       
         
         
             
             
         
       
     
   
   
       21 . A compound of formula:  
     
       
         
         
             
             
         
       
     
     wherein A represents an aryl, methyl, substituted alkyl or alkenyl group.  
   
   
       22 . A compound according to  claim 21 , wherein A represents a phenyl group or a —CH 2 CH 2 AN group.  
   
   
       23 . A compound according to  claim 22 , wherein A represents a phenyl group and the phenyl group is unsubstituted or is substituted by a halo or alkyl group.  
   
   
       24 . A compound of formula:  
     
       
         
         
             
             
         
       
     
   
   
       25 . A compound of formula:  
     
       
         
         
             
             
         
       
     
     wherein A represents an alkenyl group.

Join the waitlist — get patent alerts

Track US2005240015A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.